Ole Ahlehoff Selected Research

Ole Ahlehoff Research Topics

13	Myocardial Infarction 01/2022 - 09/2010
6	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2016 - 01/2012
4	ST Elevation Myocardial Infarction 01/2022 - 12/2020
4	Cardiovascular Diseases (Cardiovascular Disease) 08/2014 - 04/2009
3	Thrombosis (Thrombus) 01/2021 - 12/2010
3	Stroke (Strokes) 08/2014 - 09/2010
3	Diabetes Mellitus 01/2014 - 09/2010
3	Atrial Fibrillation 01/2012 - 01/2011
2	Heart Failure 01/2022 - 07/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 12/2020
2	Hemorrhage 01/2020 - 10/2011
2	Rheumatoid Arthritis 08/2014 - 09/2012
1	Systolic Heart Failure 01/2022
1	Non-ST Elevated Myocardial Infarction 01/2022
1	Hyperplasia 01/2022
1	Death (Near-Death Experience) 01/2021
1	Pain (Aches) 08/2014
1	Hypertension (High Blood Pressure) 01/2012
1	Dyslipidemias (Dyslipidemia) 01/2012
1	Hypersensitivity (Allergy) 12/2010
1	Cardiomyopathies (Cardiomyopathy) 07/2010
1	Stable Angina 12/2009

3	PolymersIBA 01/2022 - 01/2020
3	insulin receptor-related receptor (IRR)IBA 01/2016 - 08/2013
3	Clopidogrel (Plavix)FDA Link 10/2012 - 09/2010
2	BESIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 11/2011
2	MetalsIBA 01/2020 - 12/2010
2	Vitamin K FDA Link 10/2011 - 01/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2011 - 05/2011
2	Proton Pump InhibitorsIBA 05/2011 - 09/2010
1	MagnesiumIBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Urokinase Plasminogen Activator ReceptorsIBA 12/2020
1	Stainless Steel (Steel, Stainless)IBA 01/2020
1	tofacitinibIBA 11/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2014
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2012
1	CholesterolIBA 01/2012
1	Angiotensin Receptor AntagonistsIBA 01/2012
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012
1	Antihypertensive Agents (Antihypertensives)IBA 01/2012
1	Methotrexate (Mexate)FDA LinkGeneric 11/2011
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2011
1	Glipizide (Glucotrol)FDA LinkGeneric 09/2010
1	Glucose (Dextrose)FDA LinkGeneric 09/2010
1	glimepiride (Amarel)FDA LinkGeneric 09/2010
1	Glyburide (Glibenclamide)FDA LinkGeneric 09/2010
1	Tolbutamide (Orinase)FDA LinkGeneric 09/2010
1	Metformin (Glucophage)FDA LinkGeneric 09/2010
1	AnthracyclinesIBA 07/2010
1	Ranolazine FDA Link 12/2009
1	TabletsIBA 12/2009

6	Drug Therapy (Chemotherapy) 01/2014 - 04/2009
5	Percutaneous Coronary Intervention 01/2022 - 09/2010
5	Stents 01/2022 - 01/2020
4	Secondary Prevention 01/2014 - 11/2011
3	Therapeutics 01/2014 - 12/2009
2	Drug-Eluting Stents 01/2020 - 12/2010
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 03/2012 - 01/2012
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022
1	Patient Readmission 09/2010
1	Cardiac Resynchronization Therapy 07/2010